GSK Licenses RA Drug from ChemoCentryx

GSK Licenses RA Drug from ChemoCentryx

There are 1 comment on the Contract Pharma Breaking News story from Jan 6, 2012, titled GSK Licenses RA Drug from ChemoCentryx. In it, Contract Pharma Breaking News reports that:

GlaxoSmithKline has exercised its option to obtain an exclusive worldwide license to further develop and commercialize ChemoCentryx's investigational drug CCX354 for the treatment of rheumatoid arthritis .

Join the discussion below, or Read more at Contract Pharma Breaking News.

Robson

Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

ChemoCentryx Discussions

Title Updated Last By Comments
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News GSK licenses experimental arthritis treatment f... (May '12) May '12 Robson 1
News GSK Exercises Option to License ChemoCentryx's ... (May '12) May '12 Robson 1
News GlaxoSmithKline Exercises Option to License Che... (May '12) May '12 Joan 1
News GSK obtains exclusive license to ChemoCentryx's... (May '12) May '12 Joan 1
News Drug developer ChemoCentryx has priced its IPO ... (May '12) May '12 Joan 1
News Market Report, "Diabetic Nephropathy - Pipeline... (May '12) May '12 Joan 1
More from around the web